Zai Lab's (HKG:9688) net loss narrowed to $41.7 million in the third quarter from $69.2 million in the year-ago period, according to a Tuesday filing with the Hong Kong stock exchange.
Loss per share at the biopharmaceutical company narrowed to $0.04 from $0.07 in the previous year.
Revenue grew 47% to $101.8 million from $69.2 million a year earlier.
Shares of the company fell 8% Wednesday morning in Hong Kong.
Price (HKD): $23.35, Change: $-1.1, Percent Change: -4.50%